 "reddy, dr reddy's")
Dr Reddy's Laboratories Limited and global medical technology company Integra LifeScinces Holdings Corporation announced on Monday that they have entered into an exclusive distribution agreement under which the Hyderabad-based generic pharma major will market and distribute DuraGen Plus and Suturable DurgaGen dural regeneration matrices for use by patients in India.
M V Ramana, executive vice-president and head of emerging markets and India business at Dr Reddy's, said, "We are delighted to partner with Integra LifeSciences. With the launch of DuraGen, we look forward to building our presence in the segment of regenerative technologies and making a difference to the lives
